Back to Search Start Over

HPV16 induces a wasting syndrome in transgenic mice: Amelioration by dietary polyphenols via NF-κB inhibition.

Authors :
Gil da Costa, Rui M.
Aragão, Sofia
Moutinho, Magda
Alvarado, Antonieta
Carmo, Diogo
Casaca, Fátima
Silva, Sandra
Ribeiro, Joana
Sousa, Hugo
Ferreira, Rita
Nogueira-Ferreira, Rita
Pires, Maria João
Colaço, Bruno
Medeiros, Rui
Venâncio, Carlos
Oliveira, Maria Manuel
Bastos, Margarida M.S.M.
Lopes, Carlos
Oliveira, Paula A.
Source :
Life Sciences. Jan2017, Vol. 169, p11-19. 9p.
Publication Year :
2017

Abstract

Cancer patients often show a wasting syndrome for which there are little therapeutic options. Dietary polyphenols have been proposed for treating this syndrome, but their usefulness in cases associated with human papillomavirus (HPV)-induced cancers is unknown. We characterized HPV16-transgenic mice as a model of cancer cachexia and tested the efficacy of long-term oral supplementation with polyphenols curcumin and rutin. Both compounds were orally administered to six weeks-old HPV16-transgenic mice showing characteristic multi-step skin carcinogenesis, for 24 weeks. Skin lesions and blood, liver and spleen inflammatory changes were characterized histologically and hematologically. Hepatic oxidative stress, skeletal muscle mass and the levels of muscle pro-inflammatory transcription factor NF-κB were also assessed. Skin carcinogenesis was associated with progressive, severe, systemic inflammation (leukocytosis, hepatitis, splenitis), significant mortality and cachexia. Curcumin and rutin totally suppressed mortality while reducing white blood cells and the incidence of splenitis and hepatitis. Rutin prevented muscle wasting more effectively than curcumin. Preservation of muscle mass and reduced hepatic inflammation were associated with down-regulation of the NF-κB canonical pathway and with reduced oxidative stress, respectively. These results point out HPV16-transgenic mice as a useful model for studying the wasting syndrome associated with HPV-induced cancers. Dietary NF-κB inhibitors may be useful resources for treating this syndrome. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00243205
Volume :
169
Database :
Academic Search Index
Journal :
Life Sciences
Publication Type :
Academic Journal
Accession number :
121133921
Full Text :
https://doi.org/10.1016/j.lfs.2016.10.031